New medical technology fundings, February 2014

Fundings for medical technology in February 2014 totaled $537 million, buoyed by the $104.7 million funding of HeartFlow, Inc.. Below is a list of the month’s top fundings:

Company fundingProduct/technology
HeartFlow, Inc., has raised $104.7 million in a round of funding according to a regulatory filingFractional flow reserve measurement for assessment of coronary artery disease
Paradigm Spine has established a $75 million credit facility with PDL BioPharma according to press reportsMinimally invasive treatments for spinal stenosis
GC Aesthetics has raised $60 million in a round of funding according to the companyBreast implants and other products in aesthetics
Direct Flow Medical, Inc., has raised $50 million in a debt funding according to press reportsAortic valve implant for treatment of mitral valve regurgitation
Seno Medical Instruments, Inc., has raised $34.6 million of a planned $39 million Series C round of funding according to press reportsOpto-acoustic imaging for diagnostics, initially targeted as an adjunct to mammography
Alimera Sciences, Inc., has raised $37.5 million in funding according to the companyOphthalmic drug-device technology
Cheetah Medical Ltd has raised $28.85 million according to a regulatory filingContinuous, non-invasive cardiac output and hemodynamic monitoring based on “bioreactance” technology

For the complete list of medtech fundings during February 2014, see link.

For a full list of the fundings in medtech since 2009, see link.

Leave a Reply